Sun Pharma
Valentina Curovic-Perisic has extensive work experience in the pharmaceutical industry. Valentina currently holds the role of Vice President - Head of Clinical Operations at SUN PHARMA since 2022. Before that, they were the Director - Clinical Management at Otsuka Pharmaceutical Companies (U.S.) from 2019 to 2022. Prior to that, Valentina worked at Novartis for many years, starting as a Sr. Clinical Research Scientist in 2004 and gradually progressing to roles such as Clinical Research Manager, Clinical Trial Head, Global Clinical Operations - Sr. Clinical Operations Manager, Associate Director - Senior Global Trials Leader, Director - Global Clinical Operations Leader, and Development Unit Head - Trial Operations Management (TOM) Pharma. Valentina was responsible for leading teams, overseeing trial operations, ensuring compliance with internal processes and regulatory requirements, and delivering high-quality trial conduct. Valentina's earlier work experience includes a role as a Clinical and Project Coordinator at Asahi Kasei America, Inc. from 1996 to 2004.
Valentina Curovic-Perisic holds a Bachelor's degree in Biological Sciences from Rutgers University (1992-1996). Valentina also obtained a Certification in ACDRS - American Course on Drug Development and Regulatory Science from the University of California, San Francisco (2011-2013). In addition, they hold a Master of Science (MS) in Health Care Management from the College of Saint Elizabeth (2010-2013). Recently, they obtained a Certification in Balanced Scorecard Professional from the Balanced Scorecard Institute and The George Washington University Center for Excellence in Public Leadership (2021).
This person is not in any teams
This person is not in any offices
Sun Pharma
21 followers
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues. See our community guideline: bit.ly/3DsQxdK